Structure Therapeutics Inc. SEC filings GPCR

Structure Therapeutics Inc. has 271 filings in SEC EDGAR's recent list, going back to Oct 21, 2021. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
10-Q Quarterly report Nov 17, 2023 Sep 30, 2023
10-Q/A Amended quarterly report Nov 17, 2023 Jun 30, 2023
10-Q/A Amended quarterly report Nov 16, 2023 Jun 30, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GPCR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
South San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1888886
Former names
ShouTi Inc. (until May 13, 2022)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.